1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 18th March 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Properties of measurements obtained during cardiopulmonary exercise testing in individuals with ME/CFS, 2020, Davenport et al

Discussion in 'ME/CFS research' started by Andy, Jun 23, 2020.

  1. Andy

    Andy Committee Member

    Messages:
    21,805
    Location:
    Hampshire, UK
    Full title: Properties of measurements obtained during cardiopulmonary exercise testing in individuals with myalgic encephalomyelitis/chronic fatigue syndrome
    Paywall, https://content.iospress.com/articles/work/wor203170
    Sci hub, https://sci-hub.tw/10.3233/WOR-203170
     
  2. Hutan

    Hutan Moderator Staff Member

    Messages:
    26,520
    Location:
    Aotearoa New Zealand
    This paper looks as though it was missed by many. From the abstract it seems important for confirming that there are real differences in CPET performance.

    The Sci Hub link isn't working. @Snow Leopard and others with an interest in exercise physiology - what did you think? What measurements looked most useful?
     
    leokitten, Amw66, Michelle and 5 others like this.
  3. mango

    mango Senior Member (Voting Rights)

    Messages:
    2,504
    Michelle, MSEsperanza, Kitty and 3 others like this.
  4. Hutan

    Hutan Moderator Staff Member

    Messages:
    26,520
    Location:
    Aotearoa New Zealand
    Thanks @mango.
    I can't see the figures on the charts and I've run out of brain power. But the differences from one test to the next aren't looking enormous.
    Screen Shot 2020-10-01 at 3.05.27 PM.png

    So, looking at ventilatory anaerobic threshold:
    VO2 increased in controls from test 1 to test 2, and decreased in ME/CFS participants.
    workload increased slightly in controls from Test 1 to test 2 (58.0 to 63.5). In ME/CFS participants, it decreased from 49.5 to 44.1.
    heart rate increased in controls, while it decreased in ME/CFS
    systolic BP increased in controls and decreased in ME/CFS

    So the findings do seem to support the idea of a drop in performance at ventilatory threshold in ME/CFS.

    But I found the paper's focus on test-re-test reliability a bit strange.
    Surely the point of the study was to prove that things change on re-test in ME/CFS? As far as I can see, they didn't make the people with ME/CFS do two sets of two CPETs.

    I don't know why there wasn't a graph of the percentage changes from test 1 to test 2 by individual for each parameter.
     
    Last edited: Oct 1, 2020
    Michelle, andypants, ukxmrv and 9 others like this.
  5. Snow Leopard

    Snow Leopard Senior Member (Voting Rights)

    Messages:
    3,819
    Location:
    Australia
    Non sci-hub link: https://workwellfoundation.org/wp-c...ned-during-CPET-in-individuals-with-MECFS.pdf

    I could have sworn I have commented on this already, but I can't find another thread!

    There is clearly an error in the manuscript, with figure 2. (B) not agreeing with the data in Table 1.
    I have asked Todd Davenport to clarify, roughly once per month since July 2nd, and he keeps saying, oh, we're busy, we'll get around to looking into it etc. I am not impressed, if my manuscript had a major error like this, I'd want to correct it ASAP.

    Since I do not know if the data is correct, I cannot comment.

    If any readers have a relationship with any of the authors of this manuscript, please kindly ask them to fix it!
     
    Michelle, ukxmrv, MSEsperanza and 5 others like this.
  6. Hutan

    Hutan Moderator Staff Member

    Messages:
    26,520
    Location:
    Aotearoa New Zealand
    Thanks @Snow Leopard, it certainly helped being able to see the figures. I see they are in fact of differences between the Day 1 test and the Day 2 test - so I had that wrong in my previous comment. I see what you mean about the charts not matching the table. No wonder I was thoroughly confused in my brain fogged state yesterday.

    Figure 1 b shows peak workload. It looks as though mean workload didn't change much for the sedentary group and increased for the ME/CFS group.

    Screen Shot 2020-10-02 at 10.03.13 AM.png

    And yet, in table 1, the mean peak workload went up for controls and down for ME/CFS.

    Screen Shot 2020-10-02 at 10.09.40 AM.png




    And for workload at ventilatory threshold, in Figure 2b the workload drops in the controls and also drops in the ME/CFS people. (It's still hard to see the chart, but all the figures on the y axis are negatives there, with 0.0 above each band.)

    Screen Shot 2020-10-02 at 10.06.12 AM.png

    And yet here's the results in Table 1:
    ..................................................Controls 1 and 2. ............. ME/CFS 1 and 2.
    Screen Shot 2020-10-02 at 10.16.54 AM.png

    The table says workload at ventilatory threshold went up for controls and down for ME/CFS.

    So, it's not even as though it's just a problem of (Test1 - Test2) vs (Test2 - Test1) i.e. the positive and negatives are inverted. The data in the charts bears no relationship to the data in the table.

    The x axis data looks wrong too. If you look at Figure 2b, the mean workload at ventilatory threshold is around 80 for ME/CFS, but in Table 1 it's more like 50.

    I have absolutely no idea what to make of all that, other than this paper is not the one to pull out to try to make the case for a consistent and abnormal decline in work rate from Day 1 CPET to Day 2 CPET.

    I agree with @Snow Leopard, this paper needs some attention. It really harms Workwell's credibility.
     
    Last edited: Oct 1, 2020
    Michelle, Kitty, ukxmrv and 6 others like this.
  7. Simon M

    Simon M Senior Member (Voting Rights)

    Messages:
    881
    Location:
    UK
    Some comments

    Strange study design

    Leaving aside the issue of some table data not matching the figures, the study has a weird design.

    The group has spent the last decade focusing on the difference in ME/CFS patients between maximum exercise tests on day two compared with day one. Now, this study aims to show that day one results can be reproduced on day 2.

    Unsurprisingly, it wasn't a huge success. At peak exertion, controls demonstrated a very high test-test reliability (ICC values 0.834-0.990) while ME/CFS subject retest reliability was only moderate to high (0.631-0.871). At ventilatory (anaerobic) threshold, all measurements showed moderate to high real reliability for patients and controls.

    After demonstrating that there is a falloff in performance on day two and a huge symptom flare, if you really want to demonstrate the reliability/reproducibility of the test, you would need to give patients the chance to completely recover from the first test before taking the second. Or, as the authors put it in their discussion section, "Future studies… In individuals with ME/CFS might give consideration to allowing for complete recovery to baseline symptomatic status".

    I just wonder if the author is designed and conducted the study with one aim in mind and perhaps the Journal said they wanted a different kind of study. I just can't make sense of it otherwise.

    But study findings do show a fall-off at Day 2 ventilatory threshold.

    Perhaps we should just look at the study as a conventional day one versus day exercise test comparing patients and sedentary controls. Sedentary was defined as exercising to the point of perspiration once a week or less. Which is better than a lot of studies, but I would expect a lot of the population is more sedentary than that.

    Assuming that the table is correct, the key finding is Vat workload
    Comparing the change between day one and day two for patients versus controls. The only significant difference was for workload at ventilatory threshold (p <0.001). Which I think confirms previous findings but perhaps with a lower p value due to the higher sample size (51 patients).

    DA30CEA9-CDA1-44CF-BD68-4CEA81788DD2.jpeg

    Even so, based on standard deviations, the effect size for patients versus controls is moderate at best (probably a bit over 0.5). That still doesn't compute with the enormous difference in energy levels experienced in PEM triggered by exertion vastly low than by exercising to exhaustion as in the study protocol. The effect size for fatigue and other symptoms is much, much bigger than that (due to migraines I can't dig out the papers but I'm sure someone could find the data easily).
     
    Last edited: Oct 2, 2020
    FMMM1, Michelle, Hutan and 6 others like this.
  8. FMMM1

    FMMM1 Senior Member (Voting Rights)

    Messages:
    2,591
    Could the weird design be due to the fact that you can't prove a negative i.e. you must test a positive. In this case they try to test the (+ve) hypothesis that day 2 performance will be the same as day 1.

    If I'm talking c--p here then feel free to point it out!
     
    andypants and Kitty like this.
  9. Snow Leopard

    Snow Leopard Senior Member (Voting Rights)

    Messages:
    3,819
    Location:
    Australia
    The null hypothesis is that there would be no difference in performance between the two days.

    This contrasts with a hypothesis of difference: either that performance would increase or decrease on the second day. (this is a two-tailed hypothesis - if you only want to test for decreased performance, this would be a single tailed hypothesis)

    The authors state:
    The authors discuss whether certain statistical measures of test-retest reliability are relevant and suggest the standard method for calculation of "minimum detectable change" (MDC) is flawed as a result:

    The "strange design" comments relate to the fact that all prior studies have found a decrease in performance on the second day (workload at ventilatory threshold), whereas this has not been found in control participants (most were healthy, but there were also controls with other diseases). The question is, is the level of change simply normal variation, or does it reflect pathology that should be detected? Hence a determining "minimum detectable change" would favour a different study design. Instead of comparing patients to controls on the 2 day CPET, patient performance on the 2 day CPET should be compared to longer time frames where the patients have had time to recover. This would limit the any within-group heterogeneity biases due to limited sample size that limited the relevance of the statistical analysis of MDC in this study.

    edit - additional quote from the authors:



    Lastly (and unfortunately), based on the rest of the statements in the discussion section, I don't believe the authors of this study really understand the relationship between effort perception, afferent feedback, cortical motor drive and ventilatory drive and metabolic factors. Hence they're unlikely to build upon this finding in a meaningful way until they dig into this more deeply.
     
    Last edited: Nov 15, 2020
    Simon M, Michelle, andypants and 2 others like this.
  10. Snow Leopard

    Snow Leopard Senior Member (Voting Rights)

    Messages:
    3,819
    Location:
    Australia
    Oh and an update on the error: Todd Davenport claims the (Figure 2. B) graph axes have been labelled incorrectly. I have no information when the manuscript will be corrected.
     
    Simon M, FMMM1, Michelle and 2 others like this.
  11. FMMM1

    FMMM1 Senior Member (Voting Rights)

    Messages:
    2,591
    Thanks @Snow Leopard maybe need a cup of tea and a clear head before I re-read this!
     
    Simon M, Andy, Michelle and 1 other person like this.
  12. Snow Leopard

    Snow Leopard Senior Member (Voting Rights)

    Messages:
    3,819
    Location:
    Australia
    But wait, there is more:

    Since Davenport et al. was attempting to replicate the "Minimum detectable change"/"Smallest real difference" statistical analysis as proposed in the following study, I provide some further analysis to cast doubt on the appropriateness of the method:

    https://www.s4me.info/threads/an-analysis-of-2‐day-cardiopulmonary-exercise-testing-to-assess-unexplained-fatigue-in-gwi-2020-falvo-et-al.16729/#post-302233

    It makes no sense to apply the MDC/SRD analysis to the ME/CFS group and the control sample size was once again too small (N=10) for this to be statistically meaningful.
     
    Last edited: Nov 15, 2020
    Amw66, Michelle, FMMM1 and 1 other person like this.

Share This Page